Skip to content

Trinity acquires Verix, adding AI-powered next-best-action and omnichannel orchestration to TrinityEDGE™.

Learn more
Back to Blog

Your Forecast Depends on More Than Brand Share: Who Owns the Other Drivers?

Mike Falvo, Executive Director, Management Advisor Commercial Insights & Advanced Analytics
Mike Falvo

Executive Director, Management Advisors, Commercial Insights and Advanced Analytics
TGaS Advisors, a division of Trinity

Forecasting’s Not-So-Hidden Opportunity: An Introduction

I have worked with Forecasting for more than 30 years. In that time, one pattern remains remarkably consistent. Forecasting and research professionals work hard to nail the assumptions and the ranges, pressure-test risks, and build scenarios. They do this while aligning stakeholders on every input.

Then primary market research (PMR) and the brand team(s) turn their attention to segmentation research, positioning, messaging, concept testing, detail-aid development, and more in the hopes of creating a strategy to achieve the forecast.

The problem: nearly all this effort is directed at one goal: driving brand share. Brand share absolutely matters. But in a typical patient-based model, brand share is only one of roughly seven assumptions that determine whether a forecast is realized. The numbers of diagnosed patients, treated patients, and covered patients, along with therapy adherence, are just as important. I see an opportunity for organizations to connect their business plans more explicitly to the forecast drivers they can influence.

This is not a criticism of brand teams, as share is where marketing has traditionally had the most control. I believe opportunities for improvement may lie in the assumptions that receive the least attention. I see this as one of the greatest opportunities facing forecasting, research, and commercial teams today. The answer starts with a simple question: who owns what?

The Hard Work Behind Every Forecast

The August 2026 TGaS Forecasting Landscape survey shows how much discipline participating forecasting teams already bring to the table:

  • Every respondent agreed that forecast assumptions are clearly documented and visible to stakeholders.
  • More than 80% agreed that forecast accuracy is routinely measured against actual performance.
  • Roughly three-quarters reported frequent collaboration with internal stakeholders to build or update forecast scenarios.

That is a strong foundation. The assumptions are visible. The accuracy is tracked. The conversations are happening, which raises an important question: Once the forecast is aligned, who owns reviewing each assumption and acting on the drivers they can influence?

Seven Assumptions, One Focus

Patient-based forecasts commonly incorporate drivers such as the following, with the structure varying by disease, therapy, and model:

  • Prevalence: How many patients have the condition?
  • Diagnosis rate: How many are diagnosed?
  • Treatment rate: How many diagnosed patients are treated?
  • Access: How many can get coverage for the brand?
  • Brand share: How many treated patients choose the brand?
  • Adherence and persistence: How closely do patients follow the prescribed dosing instructions, and how long do they stay on therapy?
  • Price: What is the price per unit used in the forecast?

Trinity’s analysis of U.S. launches illustrates why teams should look beyond brand share. Teams should prioritize other drivers according to their uncertainty and potential business impact. From 2020 to 2023, 54% of launches underperformed their pre-launch first-year forecasts, while 35% overperformed (Trinity Life Sciences). When launches fall short, access barriers can be a contributing factor. Diagnosis and persistence challenges can also affect uptake and revenue (Trinity Life Sciences) (Pharmaceutical Executive).

The good news is that leading launches already look beyond share. Trinity’s review of the 2023 launch class found that rare disease successes were driven by “early patient finding/identification and rapid access attainment.” SKYCLARYS, for example, paired patient identification with access and support services (Trinity Life Sciences). These brands did not focus on brand share alone. They addressed several forecast assumptions at once.

The Ultimate Scenario: Shared Forecast Ownership

So who connects forecast assumptions to action? In my advisory experience, no single function can do this alone. One characteristic of above benchmark organizations is a shared ownership model, in which each function owns a distinct part of the forecast.

Forecasting connects evidence, assumptions, scenarios, and business implications

  • Owns the models
  • Builds and maintains the model structure
  • Integrates inputs and scenarios
  • Monitors accuracy and flags drift
  • Keeps the forecast transparent and governed
  • Interprets scenario results and helps leaders evaluate risks, trade-offs, and decisions

Research and relevant functional experts identify, define, and validate assumptions and assess uncertainty

  • Includes Analytics, PMR, Medical, Clinical, R&D, HEOR, and other evidence functions
  • Define and validate each assumption
  • Quantify ranges and risks
  • Update assumptions as evidence changes

Commercial and relevant functional leaders own the commercial plan and execution decisions, informed by forecast outputs

  • Build the brand plan around every assumption the brand can influence
  • Fund tactics that move diagnosis, treatment, access, share, and persistence
  • Monitor execution and adjust plans as performance and conditions change

How Shared Ownership Makes Every Assumption Count

Shared ownership helps teams translate material forecast drivers into clear responsibilities and prioritized actions. When a single brand team owns the forecast, effort naturally flows to the assumption it controls best: brand share. When ownership is shared across the organization, every assumption has someone watching it and several teams acting on it. Assigned teams should own the evidence, decisions, and actions within their control and work with Forecasting to update assumptions and scenarios as conditions change.

Diagnosis: Analytics and PMR validate the diagnosis rate and flag when it lags. Commercial funds patient finding and healthcare professional (HCP) education. Medical Affairs can also raise diagnosis rates through disease-awareness education with specialists. Clinical can partner on screening and diagnostic tools that identify patients earlier.

Access: HEOR and PMR define the coverage assumption and the evidence payers need. Commercial and Market Access fund the plan to secure it. Clinical can help by building payer-relevant endpoints into trial design. Medical Affairs can engage payer medical directors with that evidence.

Persistence: Analytics tracks the persistence assumption against real-world behavior. Commercial funds patient support and adherence programs. Medical Affairs can help HCPs manage the side effects that often drive discontinuation. Patient Services provides the hub support that keeps patients on therapy.

Forecasting ties it all together, showing which assumptions carry the most revenue risk and where the brand should intervene first. No assumption is left without an owner, so changes are more likely to be identified and addressed. When all three share ownership, the forecast stops being a number the brand is measured against and instead informs the plan the brand executes.

Encouragingly, most respondents to the TGaS Forecasting Landscape survey reported that shared accountability is established within their organizations. Thirty percent of respondents reported single-owner, informal governance models (source: TGaS). The foundation is in place. The opportunity is to extend shared accountability from building the forecast to acting on priority drivers and updating assumptions.

AI as a Means, Not the Destination

This is where AI creates real leverage for all three owners. The TGaS Knowledgebase describes a future in which forecasting professionals routinely identify the assumptions that matter most and where to intervene. In that future, forecasting professionals help direct market research and commercialization efforts toward validating and improving critical assumptions. They also help the forecast become the foundation for the strategic brand plan (source: TGaS).

Depending on the available data, integrations, and tools, AI can support these activities, with human oversight of interpretation, assumption changes, and decisions:

  • For Forecasting: Monitoring available signals and flagging potential assumption changes for review
  • For Research: Helping synthesize new evidence to inform assumption updates
  • For Commercial: Exploring how alternative commercial plans could affect forecast outcomes, using evidence-based assumptions

The goal is not simply a faster forecast. The goal is a forecast that shapes where the business invests.

What Forecasting, Research, and Commercial Leaders Should Do Next

Do not treat the forecast as the end of the planning process; use it as the blueprint for the brand plan. Over the next planning cycle, leaders can:

  • Formalize shared ownership: Define who owns the models and each assumption. Identify who reviews each assumption, who owns related actions, and who responds when conditions change.
  • Build the brand plan by assumption: Make sure tactics and budget target every assumption the brand can influence, not only brand share.
  • Point research at the weakest links: Direct research toward the assumptions that carry the most uncertainty and revenue risk.
  • Track assumptions, not just accuracy: Compare observed driver performance with the assumptions used in the forecast so teams can identify deviations and determine who acts next.
  • Elevate the forecaster’s role: Position forecasters as strategic advisors who help Commercial decide where to intervene.
  • Start with one brand: Pilot shared ownership on a single launch or high-priority in-line brand before scaling.

Conclusion

For years, forecasts have been judged largely by their accuracy. That will always matter. But a forecast should do more than establish expectations. It should help teams understand the drivers of performance, prioritize actions they can influence, and revise assumptions as new evidence emerges.

Forecasting connects evidence, assumptions, scenarios, and business implications. Research and functional experts strengthen the assumptions. Commercial and relevant functional leaders own the agreed actions. Together, they turn the forecast into a shared basis for decisions, not a fixed outcome teams must deliver.

The opportunity is to move from aligning on a forecast to using it together: to guide action, evaluate trade-offs, and adapt as conditions change.

Connect Today, Own Tomorrow

Contact Us Schedule a Demo

TGaS Advisors

Unlock insights with peer-driven industry benchmarking

Learn More

Back To Top